Evidence Driven Cancer Drug Approvals In Phase II Versus Phase III Clinical Trials Within A Single-Payer Public Healthcare System
May 1, 2018, 00:00
10.1016/j.jval.2018.04.241
https://www.valueinhealthjournal.com/article/S1098-3015(18)30541-2/fulltext
Title :
Evidence Driven Cancer Drug Approvals In Phase II Versus Phase III Clinical Trials Within A Single-Payer Public Healthcare System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30541-2&doi=10.1016/j.jval.2018.04.241
First page :
Section Title :
Open access? :
No
Section Order :
1113